Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL2237508 | 0.86 | — | — | |
| SCHEMBL240567 | 0.86 | — | — | |
| Propanol SCHEMBL1011878 | 0.82 | FYN (0.39) | ALDH1A1 | |
| SCHEMBL8857003 | 0.81 | — | — | |
| Propanol SCHEMBL1011194 | 0.78 | — | — | |
| SCHEMBL17723409 | 0.75 | EPHX2 (0.35) | — | |
| SCHEMBL9862770 | 0.75 | POLB (0.34) | — | |
| SCHEMBL17723476 | 0.75 | EPHX2 (0.35) | — | |
| SCHEMBL17723316 | 0.75 | EPHX2 (0.35) | — | |
| SCHEMBL16456459 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6495636-B2 | A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT | JSR CORPORATION (JP) | 2002-12-17 | — | — | US | claimed |
| US-8754179-B2 | Light activated shape memory co-polymers | CORNERSTONE RESEARCH GROUP, INC. (US) | 2014-06-17 | — | — | US | disclosed |
| EP-1783184-B9 | Curable ink composition and oxetane compound | FUJIFILM CORP (JP) | 2011-05-11 | — | — | EP | disclosed |
| EP-1783184-B1 | Curable ink composition and oxetane compound | FUJIFILM CORP (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20100136300-A1 | CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND | FUJIFILM CORPORATION (JP) | 2010-06-03 | — | — | US | disclosed |
| US-7728050-B2 | Curable composition, ink composition, inkjet recording method, printed matter, method for producing planographic printing plate, planographic printing plate and oxetane compound | FUJIFILM CORPORATION (JP) | 2010-06-01 | — | — | US | disclosed |
| EP-1095938-B1 | OXETANE COMPOUNDS, OXETANE COPOLYMER, AND PROCESS FOR PRODUCING OXETANE COMPOUNDS | JSR CORP (JP) | 2010-01-20 | — | — | EP | disclosed |
| EP-2103639-A1 | Curable polycyclic epoxy composition, ink composition and inkjet recording method therewith | Fujifilm Corporation (JP) | 2009-09-23 | — | — | EP | disclosed |
| EP-1757635-B1 | Curable ink comprising modified oxetane compound | FUJIFILM CORP (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080021166-A1 | Light Activated Shape Memory Co-Polymers | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2008-01-24 | — | — | US | disclosed |
| EP-1799771-A2 | LIGHT ACTIVATED SHAPE MEMORY CO-POLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2007-06-27 | — | — | EP | disclosed |
| US-20070112088-A1 | Curable composition, ink composition, inkjet recording method, printer matter, method for producing planographic printing plate, planographic printing plate and oxetane compound | FUJIFILM CORPORATION | 2007-05-17 | — | — | US | disclosed |
| EP-1783184-A1 | Curable ink composition and oxetane compound | Fujifilm Corporation (JP) | 2007-05-09 | — | — | EP | disclosed |
| US-20070049651-A1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, planographic printing plate, and oxcetane compound | FUJI PHOTO FILM CO., LTD. | 2007-03-01 | — | — | US | disclosed |
| EP-1757635-A1 | Curable modified oxetane compound and ink composition comprising it | Fuji Photo Film Co., Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
| WO-2007001407-A2 | LIGHT ACTIVATED SHAPE MEMORY CO-POLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| US-6495636-B2 | A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT | JSR CORPORATION (JP) | 2002-12-17 | — | — | US | disclosed |
| US-20010002423-A1 | Oxetane compound, oxetane copolymer, and process for producing the oxetane compound | SUGIYAMA NAOKI (JP) | 2001-05-31 | — | — | US | disclosed |
| EP-1095938-A1 | OXETANE COMPOUNDS, OXETANE COPOLYMER, AND PROCESS FOR PRODUCING OXETANE COMPOUNDS | JSR Corporation (JP) | 2001-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100136300-A1 | CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND | CCNT1, ACVR2B, ACVR1B | ALDH1A1 1249/4885CHRM2 1590/4885CHRM3 2459/4885 |
| US-20010002423-A1 | Oxetane compound, oxetane copolymer, and process for producing the oxetane compound | OXER1, PYM1, AFF1 | ALDH1A1 1653/4885CHRM2 1071/4885CHRM3 2208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.